Triazoles Concept

subject area of

• A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer  Academic Article
• A novel lysosome-targeted fluorogenic probe based on 5-triazole-quinoline for the rapid detection of hydrogen sulfide in living cells  Academic Article
• Adherence to prescribing recommendations made on a provincial formulary.  Academic Article
• American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors as Adjuvant Therapy for Women With Hormone Receptor–Positive Breast Cancer: Status Report 2002  Academic Article
• Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: A systematic review  Academic Article
• Assessing Perfusion and Capillary Permeability Changes Induced by a VEGF Inhibitor in Human Tumor Xenografts using Macromolecular MR Imaging Contrast Media  Academic Article
• Assessment of Quality of Life in MA.17: A Randomized, Placebo-Controlled Trial of Letrozole After 5 Years of Tamoxifen in Postmenopausal Women  Academic Article
• Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic  T. Cruzi Carriers  Academic Article
• CYP2D6 Genotype as a Marker for Benefit of Adjuvant Tamoxifen in Postmenopausal Women: Lessons Learned  Academic Article
• Cerebral blastomycosis: a case series incorporating voriconazole in the treatment regimen  Academic Article
• Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer  Academic Article
• Clonal Expansion and Emergence of Environmental Multiple-Triazole-Resistant Aspergillus fumigatus Strains Carrying the TR34/L98H Mutations in the cyp51A Gene in India  Academic Article
• Cognitive effects of aromatase inhibitor therapy in peripubertal boys  Academic Article
• Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor–Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial  Academic Article
• Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27  Academic Article
• Computational Study of the Binding Modes of Caffeine to the Adenosine A2AReceptor  Academic Article
• Cortical and trabecular bone at the radius and tibia in postmenopausal breast cancer patients: A Peripheral Quantitative Computed Tomography (pQCT) study  Academic Article
• Discovery of a new class of cinnamyl-triazole as potent and selective inhibitors of aromatase (cytochrome P450 19A1)  Academic Article
• Discovery of a novel class of aldol-derived 1,2,3-triazoles: Potent and selective inhibitors of human cytochrome P450 19A1 (aromatase)  Academic Article
• Discovery of nonxanthine adenosine A2A receptor antagonists for the treatment of Parkinson's disease  Academic Article
• Diversity and origins of Indian multi-triazole resistant strains ofAspergillus fumigatus  Academic Article
• Effect of Letrozole Versus Placebo on Bone Mineral Density in Women With Primary Breast Cancer Completing 5 or More Years of Adjuvant Tamoxifen: A Companion Study to NCIC CTG MA.17  Academic Article
• Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes  Academic Article
• Effect of a platelet activating factor antagonist, WEB 2086, on allergen induced asthmatic responses.  Academic Article
• Effective, selective and specific inhibition of COX-1 may overcome the “aspirin paradox”  Academic Article
• Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial  Academic Article
• Effects of platelet-activating factor on ion transport in isolated rat jejunum  Academic Article
• Efficacy of Letrozole Extended Adjuvant Therapy According to Estrogen Receptor and Progesterone Receptor Status of the Primary Tumor: National Cancer Institute of Canada Clinical Trials Group MA.17  Conference Paper
• Efficacy, Toxicity, and Quality of Life in Older Women With Early-Stage Breast Cancer Treated With Letrozole or Placebo After 5 Years of Tamoxifen: NCIC CTG Intergroup Trial MA.17  Academic Article
• Endocrine and targeted manipulation of breast cancer: Summary statement for the Sixth Cambridge Conference  Academic Article
• Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2– Advanced Breast Cancer  Academic Article
• Evaluating the Feasibility of Performing Window of Opportunity Trials in Breast Cancer  Academic Article
• Evidence of unique genetic diversity in Aspergillus fumigatus isolates from Cameroon  Academic Article
• Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial  Academic Article
• Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years  Academic Article
• Fanconi Syndrome Secondary to Deferasirox in Diamond-Blackfan Anemia: Case Series and Recommendations for Early Diagnosis  Academic Article
• Genome-Wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors  Academic Article
• Guanosine-induced increase in free cytosolic calcium concentration in mouse astrocytes in primary cultures: Does it act on an A3 adenosine receptor?  Academic Article
• HSP90 inhibition alters the chemotherapy-driven rearrangement of the oncogenic secretome  Academic Article
• High non-compliance in the use of letrozole after 2.5years of extended adjuvant endocrine therapy. Results from the IDEAL randomized trial  Academic Article
• Human and ecological risk assessment of a crop protection chemical: a case study with the azole fungicide epoxiconazole  Academic Article
• Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole  Academic Article
• Inhibition of the contraction of the ductus arteriosus to oxygen by 1-aminobenzotriazole, a mechanism-based inactivator of cytochrome P450  Academic Article
• Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17  Academic Article
• Investigation of aryl halides as ketone bioisosteres: Refinement of potent and selective inhibitors of human cytochrome P450 19A1 (aromatase)  Academic Article
• Late Extended Adjuvant Treatment With Letrozole Improves Outcome in Women With Early-Stage Breast Cancer Who Complete 5 Years of Tamoxifen  Academic Article
• Limited evidence of fungicide-driven triazole-resistant Aspergillus fumigatus in Hamilton, Canada  Academic Article
• Mono and dinuclear areneruthenium(ii) triazoles by 1,3-dipolar cycloadditions to a coordinated azide in ruthenium(ii) compounds  Academic Article
• Multiple Fungal Brain Abscesses in a Child with Acute Lymphoblastic Leukemia  Academic Article
• Nefazodone in Social Phobia  Academic Article
• Nefazodone in the Treatment of Generalized Social Phobia  Academic Article
• New onset vasomotor symptoms but not musculoskeletal symptoms associate with clinical outcomes on extended adjuvant letrozole – Analyses from NCIC CTG MA.17  Academic Article
• Novel males' capacity to disrupt early pregnancy in mice (Mus musculus) is attenuated via a chronic reduction of males' urinary 17β-estradiol  Academic Article
• Obesity and Hormone Therapy in Breast Cancer: An Unfinished Puzzle  Academic Article
• Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05)  Academic Article
• Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor-positive breast cancer: NCIC CTG MA.27  Academic Article
• Palbociclib in hormone receptor positive advanced breast cancer: A cost-utility analysis  Academic Article
• Pharmacokinetic Interaction Between Voriconazole and Efavirenz at Steady State in Healthy Male Subjects  Academic Article
• Pharmacokinetic Interaction between Voriconazole and Methadone at Steady State in Patients on Methadone Therapy  Academic Article
• Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease  Academic Article
• Phase 1b Study of New Posaconazole Tablet for Prevention of Invasive Fungal Infections in High-Risk Patients with Neutropenia  Academic Article
• Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease  Academic Article
• Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker  Academic Article
• Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17  Academic Article
• Randomized Trial of a Telephone-Based Weight Loss Intervention in Postmenopausal Women With Breast Cancer Receiving Letrozole: The LISA Trial  Academic Article
• Reduced capillary perfusion and permeability in human tumour xenografts treated with the VEGF signalling inhibitor ZD4190: an in vivo assessment using dynamic MR imaging and macromolecular contrast media  Academic Article
• Reduction in Endometrioma Size with Three Months of Aromatase Inhibition and Progestin Add-Back  Academic Article
• Remission of Macroglobulinemia during Anastrozole Treatment for Breast Cancer  Academic Article
• Risk Factors for Voriconazole Hepatotoxicity at 12 Weeks in Lung Transplant Recipients  Academic Article
• Serotonergic agents in the treatment of social phobia in children and adolescents: A case series  Academic Article
• Steady-State Pharmacokinetic and Safety Profiles of Voriconazole and Ritonavir in Healthy Male Subjects  Academic Article
• Subtherapeutic Posaconazole Exposure and Treatment Outcome in Patients With Invasive Fungal Disease  Academic Article
• The best use of adjuvant endocrine treatments  Conference Paper
• The extended adjuvant NCIC CTG MA.17 trials: Initial and rerandomization studies  Academic Article
• Treatment-Associated Musculoskeletal and Vasomotor Symptoms and Relapse-Free Survival in the NCIC CTG MA.27 Adjuvant Breast Cancer Aromatase Inhibitor Trial  Academic Article
• Use of ErbB-1 and ErbB-2 to Select Endocrine Therapy for Breast Cancer: Will It Play in Peoria?  Academic Article
• Use of letrozole challenge test to adjust gonadotropin dose in non–down-regulated cycles  Academic Article